Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

1,019.49
+8.380.83%
Post-market: 1,019.490.00000.00%19:30 EDT
Volume:142.23K
Turnover:145.28M
Market Cap:63.76B
PE:38.89
High:1,030.36
Open:1,020.29
Low:1,013.75
Close:1,011.11
52wk High:1,058.69
52wk Low:661.85
Shares:62.54M
Float Shares:62.45M
Volume Ratio:0.42
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.57
PE(LYR):52.09

Loading ...

Argenx SE Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

argenx Q2 EPS $7.32 Beats $6.24 Estimate, Sales $1.542B Beat $1.442B Estimate

Benzinga Earnings
·
Jul 23

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Argenx Se (ARGX)

TIPRANKS
·
Jul 22

Movement Alert|Argenx SE Rises 3.25% in Regular Trading, Bullish Sentiment Builds Ahead of Q2 Earnings Release

Market Focus
·
Jul 22

Argenx is Maintained at Buy by Citigroup

Dow Jones
·
Jul 22

Argenx price target raised to $1,182 from $1,152 at Citi

TIPRANKS
·
Jul 21

Argenx SE Expected to Post Earnings of $6.16 a Share - Earnings Preview

Reuters
·
Jul 21

Earning Preview: Argenx SE this quarter’s revenue is expected to increase by 53.14%, and institutional views are bullish

Earnings Agent
·
Jul 16

Analysts’ Top Healthcare Picks: Argenx Se (ARGX), Nuvation Bio (NUVB)

TIPRANKS
·
Jul 13

Movement Alert|Argenx SE Falls 3.66% in Regular Trading, Trading at 877.51 USD

Market Focus
·
Jul 11

European Equities Traded in the US as American Depositary Receipts Decline Friday

MT Newswires Live
·
Jul 10

Argenx Targets Graves’ Disease With New Phase 3 Trial: What Investors Should Know

TIPRANKS
·
Jul 09

Argenx is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 02

Movement Alert|Argenx SE Rises 3.02% in Regular Trading, Trading at $942.51

Market Focus
·
Jul 02

Movement Alert|Argenx SE Falls 3.05% in Regular Trading, Trading at $899.435

Market Focus
·
Jul 02

Investors See European Pharma Stocks as Funding Source for AI Trades

Dow Jones
·
Jun 30

Argenx Analyst Is Bullish Despite Changes To Phase 3 Myositis Study

Benzinga
·
Jun 26

Movement Alert|Argenx SE Intraday Rise 4.21%, BNP Paribas Initiates Coverage with Outperform Rating and $1,219 Target

Market Focus
·
Jun 26

Argenx Price Target Maintained with a $940.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 25

Wedbush Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
Jun 24